Mortality after laparoscopic adjustable gastric banding: results from an anonymous questionnaire to ASBS members.
BACKGROUND
Laparoscopic adjustable gastric banding (LAGB) approved 6 years ago by the Federal Drug Administration is considered a safe and simple procedure for weight loss with a reported low mortality rate (0.05%) in the literature. The aim of the study was to probe the membership of the American Society for Bariatric Surgery (ASBS) to elucidate the incidence and possible causes of unreported operative and late mortality.


METHODS
A simple questionnaire on early (30 days) and late mortality after LAGB and reoperation for banding was sent to 1,437 of 2,500 members of ASBS. Incidences and causes were studied.


RESULTS
Of the 1,437 questionnaires sent, 453 (31%) were returned. Sixty-eight of the surgeons did not do any LAGBs, 350 had no operative mortalities, and 35 (9%) reported at least one operative mortality and had a total of 36 operative deaths and 19 late deaths, for a grand total of 55. Five additional deaths occurred after reoperations for LAGB, following removal, revisions, or conversions to another bariatric procedure. Of 62 deaths, the causes were: 20 (33%) cardiac origin, 11 (18%) thromboembolic, ten (16%) GI perforations, three (5%) bleedings, and 18 miscellaneous. Of all deaths, 40% occurred remotely from the band insertion date.


CONCLUSIONS
Although LAGB is technically simple, it carries a non-negligible short- and long-term mortality, with the majority being cardiac or thromboembolic. Late mortalities from LAGB and reoperations appear to be under-reported.
Gagner
Michel
M
Mount Sinai Medical Center, Florida International University, 4300 Alton Road, Miami Beach, FL 33140, USA. gagner.michel@gmail.com
Milone
Luca
L
Trelles
Nelson
N
D035041:Anonymous Testing; D052938:Bariatric Medicine; D002423:Cause of Death; D015391:Gastroplasty / Q000379:methods / Q000401:mortality*; D006801:Humans; D015994:Incidence; D010535:Laparoscopy / Q000379:methods / Q000401:mortality*; D009203:Myocardial Infarction / Q000453:epidemiology; D012086:Reoperation; D012955:Societies, Medical / Q000706:statistics & numerical data; D011795:Surveys and Questionnaires; D013923:Thromboembolism / Q000453:epidemiology; D013997:Time Factors
Obes Surg. 2000 Feb;10(1):26-32
10715640
Obes Surg. 2003 Jun;13(3):404-11
12841902
Cleve Clin J Med. 2006 Mar;73 Suppl 1:S51-6
16570549
Obes Surg. 2005 May;15(5):641-7
15946454
Chirurg. 1998 Feb;69(2):180-5
9551262
Am J Forensic Med Pathol. 2005 Sep;26(3):297-301
16121091
Am Surg. 2004 Feb;70(2):146-9; discussion 149-50
15011918
Obes Surg. 2004 Aug;14(7):986-90
15329190
Obes Surg. 2003 Dec;13(6):918-20
14738682
JAMA. 2004 Oct 13;292(14):1724-37
15479938
Obes Surg. 1999 Aug;9(4):374-80
10484296
Obes Surg. 2005 Jun-Jul;15(6):849-52
15978157
J Am Coll Surg. 2008 Apr;206(4):664-9
18387472
Surg Obes Relat Dis. 2006 Mar-Apr;2(2):112-6
16925333
Obes Surg. 2003 Dec;13(6):819-25
14738663
Obes Surg. 2007 Jan;17(1):39-44
17355767
Am J Surg. 2002 Aug;184(2):97-102
12169351
Obes Surg. 2007 Feb;17(2):168-75
17476867
Obes Surg. 2002 Aug;12(4):564-8
12194552
Surg Laparosc Endosc Percutan Tech. 2001 Aug;11(4):229-34
11525366
Obes Surg. 2005 Jan;15(1):76-81
15760503
N Engl J Med. 2004 Dec 23;351(26):2683-93
15616203
Zentralbl Chir. 2002 Dec;127(12):1038-43
12529816
Obes Surg. 2004 May;14(5):648-54
15186633
Obes Surg. 2000 Jun;10(3):266-8
10929160
Obes Surg. 2006 Oct;16(10):1272-7
17059734
Surg Endosc. 1994 Nov;8(11):1354-6
7831615
Surg Endosc. 2003 Mar;17(3):409-12
12457216
J Gastrointest Surg. 2005 Jan;9(1):30-9; discussion 40-1
15623442
Obes Surg. 1997 Jun;7(3):198-202
9730548
Obes Surg. 2006 Jul;16(7):829-35
16839478
Surg Endosc. 2004 Mar;18(3):543-6
14752627
Thromb Haemost. 2007 Feb;97(2):171-5
17264942
Semin Laparosc Surg. 2000 Mar;7(1):55-65
10735916
Obes Surg. 2005 Apr;15(4):576-9
15946442
Surg Endosc. 2004 Jul;18(7):1082-4
15156394
Surg Endosc. 1997 Mar;11(3):268-71
9079607